Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Case report

Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report

Authors: Weiqian Mo, Feng Wang, Chuanen Zhou, Tinghe Ma, Zhaojun Pan, Min Xie, Haoyan Ren, Yongwu Xie

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Congenital bile acid synthesis disorder type 3 caused by oxysterol 7α-hydroxylase deficiency is an extremely rare genetic liver disease. As it may cause rapid progression to end-stage liver disease, a high cautiousness in diagnosis and early treatment are required. Here we describe the first case of congenital bile acid synthesis disorder type 3 in China that was confirmed by genetic analysis.

Case presentation

A 5-month-old Chinese male infant suffered skin yellowing since birth. The patient showed significantly increased alanine transaminase, aspartate transaminase, and total and direct bilirubin levels, and enlarged liver at admission. Whole-exome sequencing confirmed homozygous mutation in the CYB7B1 gene that encodes oxysterol 7α-hydroxylase. Ursodeoxycholic acid treatment significantly mitigated the condition of the patient and lowered biochemical indicators. Unfortunately, the patient developed septicemia and gave up treatment.

Conclusions

The patient was successfully treated with ursodeoxycholic acid, which has not been reported previously. Ursodeoxycholic acid replacement therapy is an effective and affordable treatment for congenital bile acid synthesis disorder type 3 caused by oxysterol 7α-hydroxylase deficiency.
Literature
3.
go back to reference Devaraj NK, Aneesa AR, Abdul Hadi AM, Shaira N. Topical corticosteroids in clinical practice. Med J Malaysia. 2019;74(2):187–9.PubMed Devaraj NK, Aneesa AR, Abdul Hadi AM, Shaira N. Topical corticosteroids in clinical practice. Med J Malaysia. 2019;74(2):187–9.PubMed
4.
10.
go back to reference Rinawi F, Iancu TC, Hartman C, et al. Fat malabsorption due to bile acid synthesis defect. Isr Med Assoc J. 2015;17(3):190–2.PubMed Rinawi F, Iancu TC, Hartman C, et al. Fat malabsorption due to bile acid synthesis defect. Isr Med Assoc J. 2015;17(3):190–2.PubMed
12.
go back to reference Wu Y, Li X, et al. 3β-hydroxy-△5-C27 steroid dehydrogenase deficiency in on family: two cases report. Chin J Clin Pediatr. 2016;34(4):253–7. Wu Y, Li X, et al. 3β-hydroxy-△5-C27 steroid dehydrogenase deficiency in on family: two cases report. Chin J Clin Pediatr. 2016;34(4):253–7.
Metadata
Title
Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report
Authors
Weiqian Mo
Feng Wang
Chuanen Zhou
Tinghe Ma
Zhaojun Pan
Min Xie
Haoyan Ren
Yongwu Xie
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03365-z

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue